I wanted to share with my friends about a very pleasant and surprising
phone call I received yesterday evening. It was from the Central
Arthritis Foundations (Texas area) Senior VP. I have the honor of
meeting her last year at the Arthritis Summit in DC, along with several
other incredible people! Each have touched my life in so many ways. She
was talking to me about the Summit, plus we have a "bill" in the Texas
legislature about "governing" over the "bio-similars" here in our state.
Rules to make sure patients get these when they are available, for the
reasons why they are being made, which is expense, a major factor for
patients. But, the bill is to protect the patient, the physicians, the
pharmacies, so that things run smoothly, and patients get the
"alternative" if available and if that is what their physicians deem to
be okay for them. Anyway, we are having some of our Texas Arthritis
Advocates go to Austin next week, and "testify" in front of the
legislature about the bill we are supporting, and so forth. If you are
here in TX, and these medications will some time in the future apply to
you, someone you know and so forth, I wanted to let you know the number
of the bill, so you can be familiar with it. It is Bill Support HB 751 /
SB 542. OF course the biosimilar medications will definitely be a huge
thing for those of us with autoimmune illnesses, arthritis illnesses, as
well as other diseases also. They will be something that can help many
of us get medications we need, but at a lesser price, which makes them
available to many, many more of us. As we go along with this particular
bill in our Texas Legislative body, you will see it come up I am sure
along the way. It is one you will probably want to keep your eyes on,
and we hope we have all the support we can here in TX, in order to get
these medications to our fellow Texans as they become available. So, I
was invited to go to Austin next week and "testify" in behalf of the AF.
I am not sure as of yet, if I will be able to make the trip. I missed
Pam's email I believe due to of course "spam" filters, so the original
email didn't get to me. She resent it yesterday, so I am looking over
the information now, and if things work out, I may consider going down
to Austin next week to go in front of the legislature in support of
getting this bill passed. I am excited to know over these next 10 years
or so, we will be seeing hopefully MANY more of these types of
medications, that will save patients billions of dollars and also allow
them to have them much more affordable. I wish everyone a good weekend.
It is dreary and appears as if we could almost have thunderstorms. The
humidity has to be 100% PLUS!!! Insane for sure... from one extreme to
the other... and between my own joints and pain, Jim's issues since the
wreck, and even my two dogs... I saw them struggling somewhat with
"stiffness" and some pain in their joints too. I will "post" more about
this bill on my blog and the information on it so you can also do your
own research!
HERE IS THE WORDING TO THE TEXAS BILL :
Support HB 751 / SB 542
To Allow Texas Pharmacists to Substitute Interchangeable Biological Products,
Help Remove Barriers to Lower Cost Drugs and Ensure Patient Safety.
What the legislation does:
HB 751 / SB 542 updates the Texas Pharmacy Practice Act.
Provides Texas pharmacists with the ability to dispense safe and less expensive biologic medications to patients, by allowing substitution of an FDA-approved interchangeable biologic for an innovator biologic brand product.
Current Texas law does not allow pharmacists to substitute any biologic drug products; therefore, pharmacists will be required to obtain advanced approval from the prescriber before they are allowed to substitute an FDA-approved interchangeable biologic for a brand name biologic. HB 751 / SB 542 removes this hurdle.
The current pharmacy practice act has specific rules that must be followed to ensure safe generic substitution of traditional drugs. HB 751 / SB 542 updates these laws to include a similar process to ensure safe biologic substitution. Biosimilars are expected on the market in 2015.
Assures that only FDA-approved “interchangeable” biologic products may be substituted without prior prescriber consent. This is similar to substitution requirements of generic substitution.
Retains the authority of physicians to call for Dispense as Written or DAW. This is identical to the authority they have with generic substitution.
Ensures pharmacist communication with the patient about the substitution, in the same way they are notified about a generic substitution.
Because biologic products differ from generics in complexity and are not identical chemical products, HB 751 / SB 542 ensures there will be transparent communication between pharmacists and prescribing physicians to ensure the patient’s medical record reflects which specific product(s) have been dispensed. This information can be relayed after the prescription is dispensed to alleviate the need to wait for pre-approval, as current law requires.
Why support HB 751 / SB 542:
HB 751 / SB 542 recognizes the growing use of interoperable electronic health records and electronic prescribing records, allowing such systems to be used by a patient’s health care team to communicate regarding a patient’s complete medication history.
HB 751 / SB 542 will streamline the substitution process by allowing pharmacists to substitute an FDA approved interchangeable biologic without first seeking approval.
HB 751 / SB 542 will increase access to lower cost drugs for patients. Biosimilars are forecast to lead to a $44.2 billion reduction in direct spending on brand-name biologics from 2014 to 2024, according to the Rand Corporation.
We are among the Texas patient and provider groups that have studied interchangeable biologic substitution and agree with the principles for safe substitution included in HB 751 / SB 542. Please vote yes!
HERE IS the information from the Arthritis Foundation and some of the other organizations supporting the bill.
